Bionic pancreas trial aims to simplify diabetes care
NCT ID NCT07011147
Summary
This study is testing whether a device called the iLet Bionic Pancreas can help adults with type 1 or type 2 diabetes better manage their blood sugar when it is prescribed and monitored by their regular primary care doctor. Researchers will compare 13 weeks of using the automated insulin delivery system to 13 weeks of the participants' usual care routine to see which leads to better blood sugar control. The goal is to see if this advanced technology can work effectively in everyday primary care settings, not just specialized diabetes clinics.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Massachusetts General Hospital
NOT_YET_RECRUITINGBoston, Massachusetts, 02114, United States
Contact Email: •••••@•••••
Contact
-
University of Colorado Anschutz Medical Campus
RECRUITINGAurora, Colorado, 80045, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.